Disclosed are novel aminoindazole urea derivatives of formula (I), wherein R, R, R, R, R, X, and Y have the meanings indicated in claim 1. Said aminoindazole urea derivatives are SGK inhibitors and can be used for the treatment of SGK-related diseases and ailments such as diabetes, obesity, metabolic syndrome (dyslipidemia), systemic and pulmonary hypertension, cardiovascular diseases, and kidney diseases, more generally for any kind of fibroses and inflammatory processes.
